Evidence map›Paper›PMID 37592015›Full record

ArticleNature immunology2023

Baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology.

Robert C Mettelman, Aisha Souquette, Lee-Ann Van de Velde, Kasi Vegesana, E Kaitlynn Allen, Christina M Kackos, Sanja Trifkovic, Jennifer DeBeauchamp, Taylor L Wilson, Deryn G St James and 7 more

Abstract read
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Antiviral CD4Communications medicine · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Multivariate Host-Pathogen Interactions Driving Heterogeneous Viral Shedding and CD8medRxiv : the preprint server for health sciences · 2025
    Article
  17. Article
  18. Review
  19. Review
  20. Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Robert C Mettelman *Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-3527-5616
Aisha Souquette *Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-6197-5870
Lee-Ann Van de VeldeDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Kasi VegesanaDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-8847-3774
E Kaitlynn AllenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-3067-751X
Christina M KackosDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sanja TrifkovicDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-0710-9514
Jennifer DeBeauchampDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA.
Taylor L WilsonDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Deryn G St JamesDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0009-0002-7410-5588
Smrithi S MenonDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-1262-0843
Timothy WoodInstitute of Environmental Science and Research Limited (ESR), Wallaceville Science Centre, Upper Hutt, New Zealand.
Lauren JelleyInstitute of Environmental Science and Research Limited (ESR), Wallaceville Science Centre, Upper Hutt, New Zealand.
Richard J WebbyDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA. richard.webby@stjude.org.ORCID http://orcid.org/0000-0002-4397-7132
Q Sue Huang *Institute of Environmental Science and Research Limited (ESR), Wallaceville Science Centre, Upper Hutt, New Zealand. sue.huang@esr.cri.nz.ORCID http://orcid.org/0000-0002-3923-5195
Paul G Thomas *Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA. paul.thomas@stjude.org.ORCID http://orcid.org/0000-0001-7955-0256
SHIVERS-II Investigation Team

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00016 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WEBBY, RICHARD · 2021 to 2025
$91.4M
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)U01AI144616 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GORDON, AUBREE L, THOMAS, PAUL G. · 2019 to 2025
$43.7M
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSESU01AI150747 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2020 to 2024
$5.9M
Immunobiology of Influenza Virus-related Critical Illness in Young HostsR01AI154470 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI RANDOLPH, ADRIENNE G, THOMAS, PAUL G. · 2020 to 2024
$4.7M
Investigating the cellular responses to influenza virus infection and the origins of first exposure immune imprintingF32AI157296 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI METTELMAN, ROBERT C · 2021 to 2023
$210k
NIAID NIH HHS 75N93019C00052NIAID NIH HHS 75N93021C00016NIAID NIH HHS F32 AI157296NIAID NIH HHS HHSN272201400006CNIAID NIH HHS R01 AI154470NIAID NIH HHS U01 AI144616NIAID NIH HHS U01 AI150747
6 · The paper itself

Abstract

Evidence suggests that innate and adaptive cellular responses mediate resistance to the influenza virus and confer protection after vaccination. However, few studies have resolved the contribution of cellular responses within the context of preexisting antibody titers. Here, we measured the peripheral immune profiles of 206 vaccinated or unvaccinated adults to determine how baseline variations in the cellular and humoral immune compartments contribute independently or synergistically to the risk of developing symptomatic influenza. Protection correlated with diverse and polyfunctional CD4

Indexed as

Communicable DiseasesInfluenza, HumanOrthomyxoviridaeOrthomyxoviridae InfectionsAdultCD8-Positive T-LymphocytesHumans

Identifiers

PMID37592015
PMCPMC10566627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.